NovoCure Limited

NovoCure Limitedverified

NVCR

Price:

$30.97

Market Cap:

$3.35B

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2015-10-01

Stock Exchange

NASDAQ

Ticker

NVCR

The Enterprise Value as of December 2024 (TTM) for NovoCure Limited (NVCR) is 3.84B

According to NovoCure Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 3.84B. This represents a change of 84.82% compared to the average of 2.08B of the last 4 quarters.

NovoCure Limited (NVCR) Historical Enterprise Value (quarterly & annually)

How has NVCR Enterprise Value performed in the past?

The mean historical Enterprise Value of NovoCure Limited over the last ten years is 5.17B. The current 3.84B Enterprise Value has changed 7.32% with respect to the historical average. Over the past ten years (40 quarters), NVCR's Enterprise Value was at its highest in in the June 2021 quarter at 23.18B. The Enterprise Value was at its lowest in in the December 2016 quarter at 677.52M.

Quarterly (TTM)
Annual

Average

5.17B

Median

2.51B

Minimum

583.45M

Maximum

17.67B

NovoCure Limited (NVCR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NovoCure Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 170.53%

Maximum Annual Enterprise Value = 17.67B

Minimum Annual Increase = -76.14%

Minimum Annual Enterprise Value = 583.45M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.94B-76.14%
20228.15B0.17%
20218.13B-53.99%
202017.67B116.06%
20198.18B165.34%
20183.08B70.58%
20171.81B170.53%
2016668.08M14.51%
2015583.45M-61.86%
20141.53B8.38%

NovoCure Limited (NVCR) Average Enterprise Value

How has NVCR Enterprise Value performed in the past?

The current Enterprise Value of NovoCure Limited (NVCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.07B

5-year avg

8.82B

10-year avg

5.17B

NovoCure Limited (NVCR) Enterprise Value vs. Peers

How is NVCR’s Enterprise Value compared to its peers?

NovoCure Limited’s Enterprise Value is less than Globus Medical, Inc. (0), less than Insulet Corporation (11.28B), less than Inspire Medical Systems, Inc. (18.96B), less than Inari Medical, Inc. (5.46B), greater than TransMedics Group, Inc. (3.13B), greater than InMode Ltd. (2.33B), greater than Integer Holdings Corporation (1.28B), less than CONMED Corporation (5.66B), greater than LivaNova PLC (3.06B), greater than iRhythm Technologies, Inc. (2.87B), greater than Heska Corporation (3.01B), greater than ShockWave Medical, Inc. (1.26B), less than Penumbra, Inc. (13.06B), less than Masimo Corporation (9.17B), less than null (9.71B),

Build a custom stock screener for NovoCure Limited (NVCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovoCure Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovoCure Limited (NVCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovoCure Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NovoCure Limited's Enterprise Value?

What is the highest Enterprise Value for NovoCure Limited (NVCR)?

What is the 3-year average Enterprise Value for NovoCure Limited (NVCR)?

What is the 5-year average Enterprise Value for NovoCure Limited (NVCR)?

How does the current Enterprise Value for NovoCure Limited (NVCR) compare to its historical average?